TRIM17 and gastric cancer: This regulatory pattern is different from the mechanism by which TRIM17 inhibits apoptosis by degrading BAX in gastric cancer [17], suggesting that TRIM17 may exert a pro-cancer effect by targeting specific substrates in different tumors.